NL-OMON46028撤回2 期
ong-term follow-up of patients previously treated with autologous T cells genetically modified with retroviral vectors. - Long-term follow up of patients treated with a CAR T-cell
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients must have received an AUTO CAR T cell therapy on a clinical treatment study.
- •Patients must have provided informed consent for long-term follow-up study prior to participation.
- •Patients must be able to comply with the study requirements.
排除标准
- •- There are no specific exclusion criteria for this study.
研究者
相似试验
进行中（未招募）
1 期
ong-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors.CTIS2024-511684-28-00Autolus Limited111
进行中（未招募）
1 期
ong-term follow-up of patients previously treated with an Autolus CAR T cell therapyEUCTR2016-004867-38-NLAutolus Limited500
进行中（未招募）
1 期
ong-term follow-up of patients previously treated with an Autolus CAR T cell therapyEUCTR2016-004867-38-GBAutolus Limited500
进行中（未招募）
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中（未招募）
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864EUCTR2016-000297-38-FRInstitut de Recherches Internationales Servier (I.R.I.S)200